Scientists Just Discovered a Hidden Way Neurons Die – And It Could Explain Alzheimer’s, Parkinson’s & More

In a groundbreaking discovery, scientists have revealed an unexpected and previously underappreciated pathway through which brain cells—neurons—can perish: a form of iron-dependent programmed cell death known as ferroptosis. This insight emerged from intensive research into an ultra-rare and devastating genetic condition called Sedaghatian-type spondylometaphyseal dysplasia (SSMD), a disorder that strikes infants with profound skeletal deformities, severe neurological issues including brain atrophy, cerebellar hypoplasia, and often early lethality.

The key culprit? Mutations in a single gene: GPX4, which encodes glutathione peroxidase 4—an enzyme long recognized as a master protector against lipid peroxidation in cell membranes. GPX4 functions as the primary cellular defense against ferroptosis by using glutathione to neutralize harmful lipid peroxides that accumulate when iron levels rise and trigger destructive oxidative chain reactions. In SSMD patients, specific mutations (such as the missense variant p.R152H highlighted in recent studies) disrupt a critical “fin-loop-like” structural feature in GPX4. This structural collapse impairs the enzyme’s ability to properly anchor to cell membranes, even though its core catalytic activity may remain partially intact. Without secure membrane localization, GPX4 fails to shield vulnerable lipid-rich areas, leaving neurons exposed to escalating iron-driven damage and eventual ferroptotic collapse.

To confirm this mechanism, researchers turned to powerful experimental models. In genetically modified mice engineered to lack GPX4 in specific brain regions or express the human disease-causing R152H variant neuron-specifically, cortical and cerebellar neurons degenerated progressively, accompanied by rising neuroinflammation—a hallmark of many brain disorders. Even more compellingly, scientists generated human neurons and mini-brain organoids from induced pluripotent stem cells (iPSCs) derived from SSMD patients’ skin cells. These lab-grown models faithfully recapitulated the pathology: heightened vulnerability to ferroptosis, membrane damage, and cell death mirroring what occurs in the mice.The therapeutic implications are particularly exciting. When ferroptosis was pharmacologically inhibited—using targeted compounds that block key steps in the iron-lipid peroxidation cascade—neuronal degeneration slowed dramatically in both the mouse models and patient-derived organoids. This strongly suggests ferroptosis is not merely a bystander process but a central driver of the neurodegeneration seen in SSMD.